AVEO
RhumbLine Advisers’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-20,004
| Closed | -$146K | – | 3214 |
|
|
2021
Q1 | $146K | Buy |
20,004
+73
| +0.4% | +$533 | ﹤0.01% | 2892 |
|
|
2020
Q4 | $115K | Buy |
19,931
+6,388
| +47% | +$36.9K | ﹤0.01% | 2953 |
|
|
2020
Q3 | $80K | Buy |
13,543
+215
| +2% | +$1.27K | ﹤0.01% | 2910 |
|
|
2020
Q2 | $69K | Buy |
+13,328
| New | +$69K | ﹤0.01% | 3007 |
|
|
2019
Q2 | – | Sell |
-138,373
| Closed | -$113K | – | 3046 |
|
|
2019
Q1 | $113K | Buy |
138,373
+102
| +0.1% | +$83 | ﹤0.01% | 2845 |
|
|
2018
Q4 | $221K | Buy |
138,271
+46,307
| +50% | +$74K | ﹤0.01% | 2686 |
|
|
2018
Q3 | $304K | Sell |
91,964
-671
| -0.7% | -$2.22K | ﹤0.01% | 2510 |
|
|
2018
Q2 | $209K | Buy |
+92,635
| New | +$209K | ﹤0.01% | 2715 |
|
|
2014
Q2 | – | Sell |
-70,111
| Closed | -$105K | – | 3097 |
|
|
2014
Q1 | $105K | Sell |
70,111
-2,530
| -3% | -$3.79K | ﹤0.01% | 2917 |
|
|
2013
Q4 | $134K | Sell |
72,641
-4,600
| -6% | -$8.49K | ﹤0.01% | 2927 |
|
|
2013
Q3 | $160K | Sell |
77,241
-473
| -0.6% | -$980 | ﹤0.01% | 2855 |
|
|
2013
Q2 | $194K | Buy |
+77,714
| New | +$194K | ﹤0.01% | 3001 |
|